Related Experiment Video
Updated: May 8, 2025
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.0K
The Cardiovascular Protective Function of Natural Compounds Through AMPK/SIRT1/PGC-1α Signaling Pathway
Sohrab Rahmani1,2, Ali Roohbakhsh2,3, Vahid Pourbarkhordar1,2
1Student Research Committee Mashhad University of Medical Sciences Mashhad Iran.
Food Science & Nutrition
|December 26, 2024
Summary
Natural compounds offer cardioprotective benefits against cardiovascular disease (CVD) by targeting the AMPK/SIRT1/PGC-1α pathway to improve mitochondrial function. This approach provides a foundation for novel therapeutic strategies to combat CVD.
Area of Science:
- Biochemistry
- Cardiology
- Pharmacology
Background:
- Cardiovascular disease (CVD) presents a significant global health burden.
- Mitochondrial dysfunction is a key factor in various CVDs, including heart failure and atherosclerosis.
- Natural compounds possess antioxidant and cardioprotective properties with a favorable safety profile.
Purpose of the Study:
- To identify natural compounds that can target the AMPK/SIRT1/PGC-1α pathway.
- To explore the therapeutic potential of these compounds in combating CVD.
- To investigate the link between mitochondrial function and CVD treatment.
Main Methods:
- Literature review focusing on natural compounds and their effects on cardiovascular health.
- Analysis of the AMPK/SIRT1/PGC-1α signaling pathway in the context of CVD.
- Evaluation of the antioxidative and cardioprotective mechanisms of natural compounds.
Main Results:
- The AMPK/SIRT1/PGC-1α pathway is crucial for promoting mitochondrial function during CVD.
- Certain natural compounds demonstrate the ability to activate this pathway.
- These compounds show promise for mitigating CVD injuries through improved mitochondrial function.
Conclusions:
- Targeting the AMPK/SIRT1/PGC-1α pathway with natural compounds is a viable therapeutic strategy for CVD.
- Natural compounds offer a promising avenue for developing novel cardioprotective agents.
- Further research into these compounds could lead to effective treatments for cardiovascular diseases.
Related Concept Videos
01:25cAMP-dependent Protein Kinase Pathways
6.0K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.0K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:19Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
01:29Pathophysiology of Cardiac Performance
471
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
471